Pennsylvania - Faruqi & Faruqi LLP

Preliminary Approval of Settlement with Direct Purchaser Class: In Re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (E.D. Pa.)

Value Drug Company V. Takeda Pharmaceuticals, U.S.A, Inc., Et al, No. 21-cv03500) (E.D PA.)

In re Bystolic Antitrust Litig., No. 20-cv-05735 (S.D.N.Y)

In re EpiPen Direct Purchaser Litig., No. 20-cv-0827 (D. Minn.)

In re Seroquel XR (Extended Release Quetiapine Fumarate) Litig., No. 20-cv-01076 (D. Del.)

Hesse et al. v. Godiva Chocolatiers, Inc. et al.

In re Novartis and Par Antitrust Litig., No. 18-cv-04361 (S.D.N.Y.)

In re Zetia (Ezetimibe) Antitrust Litig., No. 18-md-02836 (E.D. Va.)

In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litig., No. 18-md-2819 (E.D.N.Y.)

In re Intuniv Antitrust Litig., No. 16-cv-12653 (D. Mass.)

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

Send Us a Message

New York

685 Third Avenue 26th Floor
New York New York 10017

(877) 247-4292 / (212) 983-9330

(212) 983-9331

Los Angeles

1901 Avenue of the Stars Suite 1060
Los Angeles California 90067

(424) 256-2884

(424) 256-2885

Atlanta

3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305

(404) 847-0617

(404) 506-9534

Philadelphia

1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103

(215) 277-5770

(215) 277-5771